FORA Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

FORA Capital’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-22,643	Closed	-$287K	–	555
2022 Q1	$287K	Buy	+22,643	New	+$260K	0.05%	397

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FORA Capital's IRWD Position: Q2 2022 in Review

FORA Capital sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 22,643 shares — an estimated $287K sold.

FORA Capital first reported a position in IRWD in Q1 2022 and held it in 1 quarter. The position peaked at $287K in Q1 2022. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

FORA Capital reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
FORA Capital sold 22,643 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $287K.
FORA Capital first reported a position in Ironwood Pharmaceuticals in Q1 2022 and held it in 1 quarter.
FORA Capital's Ironwood Pharmaceuticals position peaked at $287K in Q1 2022.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on FORA Capital's 13F filing for Q2 2022, filed 11 Aug 2022.